Candel Therapeutics, Inc.
CADL
$12.17
-$0.43-3.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -711.20% | -220.08% | -109.59% | -5.85% | 78.43% |
| Total Depreciation and Amortization | -29.34% | -39.18% | -33.47% | -20.41% | -2.81% |
| Total Amortization of Deferred Charges | 887.50% | 595.45% | 405.77% | -66.13% | -56.16% |
| Total Other Non-Cash Items | 444.23% | 58.09% | 106.50% | -84.22% | -129.04% |
| Change in Net Operating Assets | 8,804.48% | -95.67% | 383.85% | -57.82% | -84.81% |
| Cash from Operations | -93.25% | -109.34% | -81.77% | -55.73% | -43.45% |
| Capital Expenditure | -122.58% | -22,400.00% | -13,533.33% | -- | -416.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -122.58% | -22,400.00% | -13,533.33% | -- | -416.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -69.32% | 0.00% | 0.00% |
| Issuance of Common Stock | 20.25% | 14,791.27% | -100.00% | -- | 348.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 37.48% | 5,116.84% | -52.24% | -301.01% | 796.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.02% | 816.02% | -61.77% | -180.31% | 300.09% |